Apricitabine
What is apricitabine? Apricitabine is an experimental nucleoside reverse transcriptase inhibitor (NRTI).
Avexa Announces End to Development of Experimental NNRTI Apricitabine 5-11-2010 Newer Anti-HIV Drugs and How to Use Them: Part I 6-23-2009 Safety Monitoring Board Says Phase 3 Trial of Experimental NRTI Apricitabine Can Go Forward Using Lower Dose 6-16-2009 New NRTI Apricitabine Demonstrates Good Safety in Early Clinical Trial 8-22-2008 Apricitabine Effective Against Drug-resistant HIV 8-01-2008